These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 9210320)
1. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system. Kostenich G; Orenstein A; Roitman L; Malik Z; Ehrenberg B J Photochem Photobiol B; 1997 May; 39(1):36-42. PubMed ID: 9210320 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429 [TBL] [Abstract][Full Text] [Related]
3. Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy. Blumenkranz MS; Woodburn KW; Qing F; Verdooner S; Kessel D; Miller R Am J Ophthalmol; 2000 Mar; 129(3):353-62. PubMed ID: 10704552 [TBL] [Abstract][Full Text] [Related]
4. Reduction of vein graft disease using photodynamic therapy with motexafin lutetium in a rodent isograft model. Yamaguchi A; Woodburn KW; Hayase M; Robbins RC Circulation; 2000 Nov; 102(19 Suppl 3):III275-80. PubMed ID: 11082401 [TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model. Griffin GM; Zhu T; Solonenko M; Del Piero F; Kapakin A; Busch TM; Yodh A; Polin G; Bauer T; Fraker D; Hahn SM Clin Cancer Res; 2001 Feb; 7(2):374-81. PubMed ID: 11234893 [TBL] [Abstract][Full Text] [Related]
7. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system. Hammer-Wilson MJ; Ghahramanlou M; Berns MW Lasers Surg Med; 1999; 24(4):276-84. PubMed ID: 10327046 [TBL] [Abstract][Full Text] [Related]
8. Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Young SW; Woodburn KW; Wright M; Mody TD; Fan Q; Sessler JL; Dow WC; Miller RA Photochem Photobiol; 1996 Jun; 63(6):892-7. PubMed ID: 8992510 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells. Renno RZ; Delori FC; Holzer RA; Gragoudas ES; Miller JW Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3963-71. PubMed ID: 11053300 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence pharmacokinetics of Lutetium Texaphyrin (PCI-0123, Lu-Tex) in the skin and in healthy and tumoral hamster cheek-pouch mucosa. Zellweger M; Radu A; Monnier P; van den Bergh H; Wagnières G J Photochem Photobiol B; 2000 Mar; 55(1):56-62. PubMed ID: 10877068 [TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy in the canine prostate using motexafin lutetium. Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly. Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245 [TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222 [TBL] [Abstract][Full Text] [Related]
14. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis. Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo comparison of argon-pumped and diode lasers for photodynamic therapy using second-generation photosensitizers. Hammer-Wilson MJ; Sun CH; Ghahramanlou M; Berns MW Lasers Surg Med; 1998; 23(5):274-80. PubMed ID: 9888323 [TBL] [Abstract][Full Text] [Related]
16. Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors. Hornung R; Hammer-Wilson MJ; Kimel S; Liaw LH; Tadir Y; Berns MW J Photochem Photobiol B; 1999 Mar; 49(1):41-9. PubMed ID: 10365445 [TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. Lilge L; Wilson BC J Clin Laser Med Surg; 1998 Apr; 16(2):81-91. PubMed ID: 9663099 [TBL] [Abstract][Full Text] [Related]
18. Phototherapy of cancer and atheromatous plaque with texaphyrins. Woodburn KW; Fan Q; Kessel D; Wright M; Mody TD; Hemmi G; Magda D; Sessler JL; Dow WC; Miller RA; Young SW J Clin Laser Med Surg; 1996 Oct; 14(5):343-8. PubMed ID: 9612202 [TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. Woodburn KW; Fan Q; Kessel D; Luo Y; Young SW J Invest Dermatol; 1998 May; 110(5):746-51. PubMed ID: 9579539 [TBL] [Abstract][Full Text] [Related]
20. Initiation of apoptosis by photodynamic therapy using a novel positively charged and water-soluble near infra-red photosensitizer and white light irradiation. Schastak S; Yafai Y; Geyer W; Kostenich G; Orenstein A; Wiedemann P Methods Find Exp Clin Pharmacol; 2008; 30(1):17-23. PubMed ID: 18389094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]